Brewers' Yeast - Helping to Cure What "Ales" You

The Canadian Cancer Society estimates that there will be 153,100 new cases of cancer and 70,400 deaths from cancer in Canada in 2006. These statistics emphasize the importance of basic research into the molecular mechanisms of cancer progression.

Scientists have found chromosome gain or loss, or aneuploidy, in nearly all major human tumour types.  A major interest in the Baetz Lab is to discern the genetic and molecular basis for chromosomal instability.  In particular we are interested in how DNA binding proteins and enzymes that regulate chromatin structure - the combination of DNA and core histone proteins - impact chromosome segregation and cell cycle progression. 

Why is Baetz using the yeast we commonly use for brewing beer to study cancer? Because the basic cellular functions of yeast are nearly identical to those of humans. If we understand the function of a protein in yeast, we'll be a lot closer to understanding its function in mammalian cells.

In addition, yeast has been the model organism for the development of functional genomic and proteomic techniques that allow for the assessment of all protein function within a cell. Thus, yeast is recognized as a powerful substitute model organism for the study of mammalian disease biology.

The Baetz Lab's current research projects combine both powerful high-throughput yeast chemical and functional genomic screens with proteomic approaches in order to assess which of yeast's 6,000 proteins play a role in maintaining chromosome balance in the cell or cell cycle progression. Once the proteins are identified traditional methods drawn from biochemistry and molecular biology are used to reveal the molecular mechanisms used by these proteins to prevent chromosome loss.

Chromatin and Chromosome Stability

Our studies on Chromatin and Chromosome Stability are proceeding on multiple fronts.

First, we are continuing our characterization of the histone acetyltransferase (HAT) NuA4 that we identified as a major regulator of chromosome stability.  NuA4 is a multisubunit protein complex and is the only essential HAT in yeast.  NuA4 mutants deficient in acetyltransferase activity have huge increase in chromosome loss.  Through integrated functional genomic and proteomic approaches we are aiming to reveal the molecular mechanisms used by NuA4 to maintain chromosome stability.  In addition, the NuA4 interactome network map we are generating will allow us to systematically determine the cellular functions of NuA4. 

Secondly, through genome-wide screens we have recently shown that the iron responsive transcription factor Aft1 has an important role in maintaining chromosome stability.   We are presently utilizing a variety of genome-wide synthetic genetic interaction screens to examining the roles of Aft1 in cell cycle progression. 

Thirdly, we are utilizing a variety of genomic and proteomic approaches in budding yeast to identify novel regulators of chromatin structure whose function contributes to genome stability.  In particular we are interesting in determining how protein noise - the variability among identical cells in the number of protein molecules for a given gene - influences genome stability.

Identification of Chemical Mode of Action

Chemicals identified by phenotypic screening are valuable genetic tools to study complex cellular process and are often attractive candidates for drug development. Identification of the mechanism of action or target of these chemicals is critical for evaluating and optimizing therapeutic agents. The Baetz laboratory exploits the cross-species conservation of biochemical pathway function between yeast and human cells to gain insights into the mode of action of various compounds. In particular the laboratory is performing cell-based robotic screening procedures with the yeast deletion mutant arrays to discover drug targets or mode of action.